MedTrace Logo

Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases

NCT01091311 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-06-08

No results posted yet for this study

Summary

Multicentric study, open label, uncontrolled phase IV in 30 patients with meibomian glands dysfunction .

Its objective is to Collect information from patients and ophthalmologists specialized in ocular surface and eyelids to anticipate how Blephasteam ® can be optimized.

This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21.

Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two uses per day) and complete a questionnaire every two days during the first week and then once a week the next two weeks.

Conditions

  • Eyelid Diseases

Interventions

DEVICE

Blephasteam

Eye lid warming goggles

Sponsors & Collaborators

  • Laboratoires Thea

    lead INDUSTRY

Principal Investigators

  • Christophe Baudouin, Professor · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

  • Frédéric Chiambaretta, Professor · University Hospital, Clermont-Ferrand

  • Serge Doan, Doctor · Hopital Bichat

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01091311 on ClinicalTrials.gov